题名 | Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results. | 链接 | https://www.ncbi.nlm.nih.gov/pubmed/24655971 |
本帖最后由 lo7ve77 于 2019-4-16 03:12 编辑
|